1ZTS:BIT
Zoetis Inc
61,60 €
arrow_downward
-0,93%(-0,58) 1 d.
2. okt., 17:26:00 GMT+2 · EUR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Simply Wall Street
·
pirms 6 stundām
Zoetis (ZTS) Stock May Sit Below Fair Value After Mixed Q2 Results
Kalkine Media
·
pirms 14 stundām
Zoetis EVP Rimma Driscoll Acquires 277.77 Phantom Stock Units via Supplemental Savings Plan
Stock Titan
·
pirms 14 stundām
An EVP acquires 321.4945 cash-settled stock-linked units at Zoetis (ZTS).
TipRanks
·
pirms 17 stundām
Zoetis Stock Slips As Board Shake-Up Disappoints
Profils
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia